financetom
Business
financetom
/
Business
/
Aura Minerals to Delist From Toronto Stock Exchange
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Aura Minerals to Delist From Toronto Stock Exchange
Sep 8, 2025 3:40 AM

06:30 AM EDT, 09/08/2025 (MT Newswires) -- Aura Minerals ( AUGO ) said Monday its application to voluntarily delist from the Toronto Stock Exchange has been approved.

Shares of the company are expected to delist from the exchange on Sept. 25. The shares will continue to trade on Nasdaq and in Brazil, the company said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Diversified Energy in talks to buy energy producer Maverick, WSJ reports
Diversified Energy in talks to buy energy producer Maverick, WSJ reports
Jan 26, 2025
Jan 26 (Reuters) - Diversified Energy ( DEC ) is in advanced talks to buy private equity-owned Maverick Natural Resources, the Wall Street Journal reported on Sunday. A deal would value Maverick at about $1.3 billion including debt, the report said, adding that it could be announced as soon as early Monday. ...
South Korea reports initial findings of Jeju Air crash to ICAO, U.S. and Thailand
South Korea reports initial findings of Jeju Air crash to ICAO, U.S. and Thailand
Jan 26, 2025
SEOUL, Jan 27 (Reuters) - South Korea's authorities investigating last month's Jeju Air plane crash have submitted a preliminary accident report to the U.N. aviation agency and to the authorities of the United States, France and Thailand, an official said on Monday. The investigation into the deadliest air disaster on the country's soil remains ongoing, the report made available on...
US FDA OKs monthly maintenance dosing for Eisai/Biogen's Alzheimer's drug
US FDA OKs monthly maintenance dosing for Eisai/Biogen's Alzheimer's drug
Jan 26, 2025
(Reuters) - The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai ( ESALF ) and partner Biogen's Alzheimer's drug Leqembi, the companies said on Monday. The drug received standard U.S. approval in 2023 after showing it slowed cognitive decline in patients with the brain-wasting disease but growth has been slow, in part because its administration...
US FDA OKs monthly maintenance dosing for Eisai/Biogen's Alzheimer's drug
US FDA OKs monthly maintenance dosing for Eisai/Biogen's Alzheimer's drug
Jan 26, 2025
Jan 27 (Reuters) - The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai ( ESALF ) and partner Biogen's Alzheimer's drug Leqembi, the companies said on Monday. The drug received standard U.S. approval in 2023 after showing it slowed cognitive decline in patients with the brain-wasting disease but growth has been slow, in part because...
Copyright 2023-2026 - www.financetom.com All Rights Reserved